Your browser doesn't support javascript.
loading
Influence of Darolutamide on Cabazitaxel Systemic Exposure.
Buck, Stefan A J; Guchelaar, Niels A D; de Bruijn, Peter; Ghobadi Moghaddam-Helmantel, Inge M; Oomen-de Hoop, Esther; Westgeest, Hans M; Hamberg, Paul; Mathijssen-van Stein, Danielle; Lolkema, Martijn P; Koolen, Stijn L W; de Wit, Ronald; Mathijssen, Ron H J.
Affiliation
  • Buck SAJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. s.buck@erasmusmc.nl.
  • Guchelaar NAD; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • de Bruijn P; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • Oomen-de Hoop E; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands.
  • Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands.
  • Lolkema MP; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • Koolen SLW; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
  • de Wit R; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Clin Pharmacokinet ; 61(10): 1471-1473, 2022 10.
Article de En | MEDLINE | ID: mdl-35895277

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Taxoïdes / Tumeurs prostatiques résistantes à la castration Limites: Humans / Male Langue: En Journal: Clin Pharmacokinet Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Taxoïdes / Tumeurs prostatiques résistantes à la castration Limites: Humans / Male Langue: En Journal: Clin Pharmacokinet Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas